Bone Gummies Cannot Carry Calcium. Here Is What They Can Do.

A 1,000 mg calcium dose is a 2.5 g tablet, not a gummy. Bone gummies work by carrying the cofactors that decide whether the calcium a customer eats from food actually gets deposited: vitamin D3, vitamin K2, magnesium and silicon.

25-50 µg
Vitamin D3 per serving
45-90 µg
K2 as MK-7 per serving
3,000 units
Minimum per SKU
Bone Gummies Cannot Carry Calcium. Here Is What They Can Do.

The Honest Limit of the Bone Gummy Format

Calcium is the nutrient customers expect to see on a bone health label, and it is the one nutrient a gummy cannot deliver at a therapeutic dose. Calcium carbonate is 40 percent elemental calcium, so 1,000 mg of elemental calcium means 2.5 g of raw material. Add sweetener, gel, acid and flavour and the piece is over 6 g, which no one chews, and the mouthfeel is dry and chalky before the flavour even loads.

That does not make the format useless. Bone mineral density is not a calcium-only outcome. Vitamin D3 governs intestinal calcium absorption, vitamin K2 activates osteocalcin so that calcium is bound into the bone matrix rather than left in circulation, magnesium is a cofactor for the enzymes that convert vitamin D to its active form, and silicon and vitamin C support collagen cross-linking in the matrix itself. Those four or five actives fit comfortably in a 4 g gummy.

So the correct brief for a bone health gummy is a cofactor product with an honest calcium position: either the label states the calcium that actually fits, 100-200 mg at most, or the product is positioned as calcium-free and paired with a dietary recommendation. We build both, and we will tell you which one the artwork has to say.

The second design decision is vitamin K2 form. MK-4 has a short half-life and needs three daily doses; MK-7 at 45-90 µg gives a single daily dose and is the form used in most of the recent bone and arterial health work. MK-7 is an oil-soluble menaquinone, so it enters the gummy as part of the emulsified oil phase, not as a water-soluble premix. If a formulator drops MK-7 into the cook as a powder, it disperses badly and the assay shows a wide spread between pieces.

The third is a safety flag that belongs on the artwork, not just in the technical file. Vitamin K interferes with warfarin and other vitamin K antagonists. Every K2 product we make carries a client-facing warning, and we ask the client to confirm it is on the final label before we release artwork.

Finally, bone claims are narrow. In the EU, calcium and vitamin D carry authorised claims for the maintenance of normal bones, magnesium contributes to normal muscle function, and vitamin K contributes to the maintenance of normal bones. Collagen and silicon have no authorised claim. A gummy that prints 'reverses bone loss' or 'treats osteoporosis' is making a drug claim in every major market, and we will not produce that artwork.

How We Build a Bone Health Gummy

Vitamin D3 in the oil phase
Cholecalciferol is oil soluble and light sensitive. We dose it as a diluted oil premix into the emulsified fat phase at 25-50 µg per serving and pack in a light-barrier format so the label claim holds at end of shelf life.
K2 as MK-7, emulsified
45-90 µg of MK-7 is a tiny oil load, but it has to be pre-emulsified with the D3 and the carrier oil. Dropping it in as powder gives uneven distribution across a 2,000 piece batch, and the assay spread shows it.
Magnesium at a dose that gells
100-200 mg elemental magnesium from magnesium citrate or glycinate fits a 4 g piece. Above that the piece softens, because the salt holds water that the gelatin or pectin network cannot tolerate.
Calcium, stated honestly
Where a client wants calcium on the label, we formulate 100-200 mg elemental calcium from calcium citrate and print exactly that. We do not stretch it to 500 mg by shrinking the piece and calling it a serving of two.
Silicon and vitamin C for the matrix
Choline-stabilised orthosilicic acid at 5-10 mg and vitamin C at 40-80 mg are both water soluble, both cheap in solids, and both support the collagen side of bone rather than the mineral side.
Collagen peptides as a second SKU
2.5-5 g of collagen peptides per serving does not fit a gummy. Where a client wants it, we quote a stick pack or a 5 g dual-piece format and keep the gummy as the cofactor SKU.

Bone Health Gummy Nutrient Table

NutrientDose with evidenceDose in a 4 g pieceConstraintOur approach
Vitamin D315-50 µg25-50 µgLight and oxygenOil premix, opaque pack
Vitamin K2 (MK-7)45-90 µg45-90 µgOil soluble, warfarin warningEmulsified with D3
Magnesium100-200 mg elemental100-200 mgSoftening above 200 mgCitrate or glycinate
Calcium500-1,000 mg100-200 mg maximum2.5 g raw material per 1 gCitrate, honest label
Silicon (ch-OSA)5-10 mg5-10 mgpH dependent stabilityBuffered to pH 4.2
Vitamin C40-80 mg40-80 mgAcid load, gel strengthAscorbic acid, buffered
Collagen peptides2.5-5 gDoes not fitSolids budgetStick pack SKU
Zinc8-11 mg8-11 mgMetallic tasteBisglycinate
Vitamin B61.4 mg1.4 mgNonePyridoxine HCl

Bone Gummy Development Sequence

01
Decide the calcium position
Calcium-free cofactor product, or a low-dose calcium claim. This single decision changes the label, the piece size and the market positioning, so it is settled before any formulation work.
02
Build the oil phase
D3 and MK-7 are pre-dissolved into a carrier oil with an emulsifier at 60 degrees, then homogenised into the base at the point where the base is cool enough not to degrade them.
03
Set the mineral load
Magnesium and any calcium are weighed as salts, not as elemental figures, and the water activity is modelled before the first cook rather than measured after it.
04
Pilot cook at 5 kg
A pilot batch confirms gel strength, aw and colour with the full mineral load, which behaves differently from a plain base even at the same solids content.
05
Shelf life with the pack
Stability runs in the actual packaging, because D3 and MK-7 loss is driven by light and oxygen ingress, and a blister and a jar give different numbers.
06
Release and scale
Commercial batch from 50,000 to 2,000,000 pieces, 4-6 week lead time, with certificates covering assay, aw, texture, microbiology and the K2 warning artwork check.

Testing a Bone Health Gummy

Vitamin D3 is assayed by HPLC on the finished gummy, and the result is compared with the label after the overage calculation. D3 degrades during shelf life at a rate that depends on the packaging, so a product in a clear jar needs a different overage from the same formula in an opaque blister.

Vitamin K2 is the harder assay. MK-7 sits in the oil phase at micrograms per piece, so the sample preparation has to extract the fat completely or the result under-reads. We run MK-7 by HPLC with fluorescence detection and report both the mean and the spread across ten pieces from the same batch.

Calcium and magnesium are measured by ICP-MS as elemental minerals. This matters most for the low-dose calcium products, where the label claims 150 mg and a 10 percent dispersion error is a labelling failure, not a rounding issue.

Texture and water activity are measured on every batch. A bone gummy with 1.4 g of mineral salts per serving is mechanically different from a fruit gummy, and the compression figure at release is the number that predicts whether the piece will crack in a blister cavity six months later.

GMPISO 22000HACCPHalalKosher

Bone Health Gummy FAQ

Can a gummy deliver 1,000 mg of calcium?+
No. 1,000 mg of elemental calcium from calcium carbonate is 2.5 g of raw material, and the finished piece would be over 6 g with an unpleasant dry texture. The practical ceiling is 100-200 mg per serving, which is why most bone gummies are cofactor products rather than calcium products.
Is a calcium-free bone gummy a legitimate product?+
Yes, if the label says what it is. Vitamin D3, K2, magnesium and silicon all have roles in bone metabolism and all fit a gummy at meaningful doses. What is not legitimate is printing 'bone health' on a piece that carries 20 mg of calcium and no cofactors.
Why MK-7 rather than MK-4?+
MK-7 has a much longer half-life, so a single 45-90 µg dose holds a steady level, while MK-4 needs multiple daily doses. MK-7 is also the form used in most recent bone and vascular work, which is what buyers search for.
Do you put the warfarin warning on the label?+
We require it. Vitamin K antagonises warfarin, and any K2 product without that warning is a regulatory exposure. We ask the client to confirm the warning is present in the final artwork before release.
What does 45-90 µg of MK-7 cost in solids?+
Almost nothing. It is an oil at micrograms per piece, so the constraint is dispersion and stability, not mass. This is the rare case where the technical difficulty is entirely in the process, not in the dose budget.
Can you add collagen to the same gummy?+
Not at 2.5-5 g. Collagen peptides at that dose need a stick pack or a 5 g two-piece format. We usually build the gummy as the cofactor SKU and the stick pack as the collagen SKU, sold as a pair.
What water activity do you run?+
0.55-0.62 depending on the mineral load. Mineral salts bind water, so a piece with 200 mg of magnesium runs higher than a plain gummy, and the gelatin or pectin level is adjusted to match rather than the specification being widened.
How long does development take?+
Four to six weeks from approved brief to commercial batch, including a 5 kg pilot cook, a sensory round and the start of accelerated stability. Novel mineral loads add about a week for texture work.
Which claims are allowed on a bone gummy?+
In the EU, calcium and vitamin D for maintenance of normal bones, magnesium for normal muscle function, vitamin K for maintenance of normal bones. Collagen and silicon have no authorised claim. Disease claims such as osteoporosis treatment are not permitted in any market we ship to.

Send Your Bone Health Brief

Tell us the market, the nutrients you want on the label and the piece size you have in mind. We will come back with a nutrient table showing what fits a gummy at a real dose, what has to move to a second format, and the claim wording that matches the destination market.

Related Pages